Janney Montgomery Scott’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,425
Closed -$242K 2611
2024
Q1
$242K Buy
8,425
+1,045
+14% +$31.4K ﹤0.01% 2465
2023
Q4
$242K Sell
7,380
-14,171
-66% -$385K ﹤0.01% 2362
2023
Q3
$600K Sell
21,551
-215
-1% -$7.03K ﹤0.01% 1648
2023
Q2
$742K Buy
21,766
+753
+4% +$23.7K ﹤0.01% 1606
2023
Q1
$632K Sell
21,013
-222
-1% -$6.88K ﹤0.01% 1579
2022
Q4
$599K Buy
21,235
+8,506
+67% +$270K ﹤0.01% 1660
2022
Q3
$418K Sell
12,729
-6,189
-33% -$227K ﹤0.01% 1802
2022
Q2
$612K Sell
18,918
-28,022
-60% -$980K ﹤0.01% 1496
2022
Q1
$2.16M Buy
46,940
+6,601
+16% +$315K 0.01% 890
2021
Q4
$2.47M Sell
40,339
-20,290
-33% -$1.4M 0.01% 873
2021
Q3
$4.53M Sell
60,629
-3,221
-5% -$270K 0.02% 624
2021
Q2
$5.91M Sell
63,850
-225
-0.4% -$19.1K 0.03% 535
2021
Q1
$5.68M Buy
64,075
+8,434
+15% +$837K 0.03% 515
2020
Q4
$5.19M Buy
55,641
+33,802
+155% +$2.69M 0.03% 531
2020
Q3
$1.39M Buy
21,839
+6,122
+39% +$359K 0.01% 951
2020
Q2
$820K Buy
15,717
+2,280
+17% +$97.8K 0.01% 1131
2020
Q1
$420K Buy
13,437
+1,116
+9% +$37.3K ﹤0.01% 1315
2019
Q4
$413K Buy
12,321
+817
+7% +$26K ﹤0.01% 1530
2019
Q3
$340K Buy
11,504
+2,877
+33% +$93.5K ﹤0.01% 1609
2019
Q2
$297K Buy
8,627
+1,658
+24% +$53.1K ﹤0.01% 1700
2019
Q1
$229K Buy
+6,969
New +$206K ﹤0.01% 1792
2018
Q4
Sell
-7,934
Closed -$265K 1934
2018
Q3
$265K Buy
+7,934
New +$251K ﹤0.01% 1781

Other funds holding ARKG

Janney Montgomery Scott's ARKG Position: Q2 2024 in Review

Janney Montgomery Scott sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 8,425 shares — an estimated $242K sold.

Janney Montgomery Scott first reported a position in ARKG in Q3 2018 and held it in 22 quarters. The position peaked at $5.91M in Q2 2021. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Janney Montgomery Scott reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Janney Montgomery Scott sold 8,425 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $242K.
  • Janney Montgomery Scott first reported a position in ARK Genomic Revolution ETF in Q3 2018 and held it in 22 quarters.
  • Janney Montgomery Scott's ARK Genomic Revolution ETF position peaked at $5.91M in Q2 2021.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Janney Montgomery Scott's 13F filing for Q2 2024, filed 25 Jul 2024.